Education
About Us
Working with TipRanks
Follow Us
Vyome Holdings (HIND)
NASDAQ:HIND
HIND Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.48 - $1,212.90
Previous CloseN/A
VolumeN/A
Average Volume (3M)579.26K
Market Cap
$9.43M
Enterprise Value-$1.27M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.52
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding673,335
10 Day Avg. Volume1,498,208
30 Day Avg. Volume579,260
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap-0.13
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Vyome Holdings News
HIND FAQ
What was Vyome Holdings’s price range in the past 12 months?
Vyome Holdings lowest stock price was $7.48 and its highest was $1212.90 in the past 12 months.
What is Vyome Holdings’s market cap?
Vyome Holdings’s market cap is $9.43M.
When is Vyome Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Vyome Holdings’s earnings last quarter?
Currently, no data Available
Is Vyome Holdings overvalued?
According to Wall Street analysts Vyome Holdings’s price is currently Overvalued.
Does Vyome Holdings pay dividends?
Vyome Holdings does not currently pay dividends.
What is Vyome Holdings’s EPS estimate?
Vyome Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vyome Holdings have?
Vyome Holdings has 673,335 shares outstanding.
What happened to Vyome Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vyome Holdings?
Currently, no hedge funds are holding shares in HIND
Company Description
Vyome Holdings
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.
Vyome Holdings (HIND) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Sintx Technologies
―
Helius Medical Technologies
―
Venus Concept
―
Movano
―
Heart Test Laboratories, Inc.
―